Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Small interfering RNA for cancer treatment: overcoming hurdles in delivery

Title: Small interfering RNA for cancer treatment: overcoming hurdles in delivery
Authors: Charbe, NB; Amnerkar, ND; Ramesh, B; Tambuwala, MM; Bakshi, HA; Aljabali, AAA; Khadse, SC; Satheeshkumar, R; Satija, S; Metha, M; Chellappan, DK; Shrivastava, G; Gupta, G; Negi, P; Dua, K; Zacconi, FC
Publisher Information: Elsevier BV
Publication Year: 2020
Collection: University of Technology Sydney: OPUS - Open Publications of UTS Scholars
Description: © 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug delivery systems are based on the difference between cancer and healthy cells. Currently, nanotechnology-based delivery systems are the most promising tool to deliver DNA-based products to cancer cells. This review aims to highlight the latest development in the lipids and polymeric nanocarrier for siRNA delivery to the cancer cells. It also provides the necessary information about siRNA development and its mechanism of action. Overall, this review gives us a clear picture of lipid and polymer-based drug delivery systems, which in the future could form the base to translate the basic siRNA biology into siRNA-based cancer therapies.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
ISSN: 2211-3835; 2211-3843
Relation: Acta Pharmaceutica Sinica B; Acta Pharmaceutica Sinica B, 2020, 10, (11), pp. 2075-2109; http://hdl.handle.net/10453/144620
Availability: http://hdl.handle.net/10453/144620
Rights: Elsevier required licence: © 2020 . This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/. The definitive publisher version is available online at https://doi.org/10.1016/j.apsb.2020.10.005 ; info:eu-repo/semantics/openAccess ; Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hostingby Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Accession Number: edsbas.CC803C0D
Database: BASE